Cite

HARVARD Citation

    Groelly, F. et al. (2022). Anti‐tumoural activity of the G‐quadruplex ligand pyridostatin against BRCA1/2‐deficient tumours. EMBO molecular medicine. 14 (3), p. n/a. [Online]. 
  
Back to record